Market Place
Sourcing Support
Enforcement Report - Week of May 29, 2024
29 May 2024 //
FDA
Dr Reddys Labs` Generic Vasopressin Receives Approval in the U.S
08 May 2024 //
FDA
Enforcement Report - Week of February 21, 2024
21 Feb 2024 //
FDA
Gland Pharma`s Generic Vasopressin Receives Approval in the U.S.
09 Feb 2024 //
FDA
Enforcement Report - Week of January 24, 2024
24 Jan 2024 //
FDA
Cipla`s Generic Vasopressin Receives Approval in the U.S.
06 Dec 2023 //
FDA
Fresenius Kabi Launches Vasopressin Injection
14 Jun 2023 //
BUSINESSWIRE
Enforcement Report - Week of May 31, 2023
31 May 2023 //
FDA
FDA Confirms Paragraph IV Patent Litigation for Vasopressin Injection
13 Feb 2023 //
FDA
Federal Circuit Rules in Favor of Eagle Pharma in Vasopressin Litigation
18 Aug 2022 //
GLOBENEWSWIRE
Aurobindo Pharma arm gets final US FDA nod for Vasopressin injection
16 Aug 2022 //
ECONOMIC TIMES
Amneal launches 4 new Generic products, including Vasopressin single-dose
11 Aug 2022 //
BUSINESSWIRE
Amneal`s Generic Vasopressin Receives Approval in the U.S.
05 Aug 2022 //
FDA
Amphastar Receives FDA Approval for Vasopressin
19 Jul 2022 //
BIOSPACE
Amphastar Pharma Generic Vasopressin Receives Approval in the U.S.
18 Jul 2022 //
FDA
FDA Confirms Para IV Patent Litigation for Vasopressin Injection
06 Apr 2022 //
FDA
Dr. Reddy`s Laboratories Launches Authorized Generic Version of VASOSTRICT Vials
09 Feb 2022 //
BUSINESSWIRE
Endo introduces ready-to-use Vasostrict in pre-mix bottles
08 Feb 2022 //
PHARMABIZ
Endo Launches Ready-to-Use VASOSTRICT in Pre-Mix Bottles
07 Feb 2022 //
PRNEWSWIRE
American Regent introduces FDA-approved Vasopressin Injection, USP
03 Feb 2022 //
PRNEWSWIRE
Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin
18 Jan 2022 //
BUSINESSWIRE
Amphastar Receives FDA Tentative Approval for Vasopressin
29 Dec 2021 //
BIOSPACE
FDA Approves Abbreviated New Drug Application for Vasopressin
21 Dec 2021 //
CONSUMER
Eagle Reports, Par Has Unilaterally Withdrawn Idea to Halt Launch of Vasopressin
20 Dec 2021 //
BUSINESSWIRE
FDA seeks FTC action after rejecting petition to block vasopressin`s generic
17 Dec 2021 //
ENDPTS
Eagle Pharm`s Generic Vasopressin Receives Approval in the U.S.
15 Dec 2021 //
FDA
Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
15 Dec 2021 //
BUSINESSWIRE
Eagle Receives Additional FDA Questions Regarding Vasopressin; Court Date Set
02 Feb 2021 //
BUSINESSWIRE
Eagle Announces Update in Vasopressin Trial; Trial Date Postponed
01 Feb 2021 //
BUSINESSWIRE
Enforcement Report - Week of December 30, 2020
30 Dec 2020 //
FDA
Roche Sees Profit Bump as Drugs and Diagnostics Stay in Demand
23 Apr 2020 //
FIERCE COVID
Endo comes out on top in its fight with FDA and bulk compounder
01 Oct 2019 //
FIERCE PHARMA
FDA Wins Court Case to Not Put Vasopressin on Compounding List
22 Aug 2019 //
RAPS
Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List
01 Mar 2019 //
PR NEWSWIRE
Vasostrict (Vasopressin) : Par Pharmaceutical vs. Amphastar Pharmaceuticals
20 Dec 2018 //
PATENT LITIGATION
Vasostrict (Vasopressin) : Par Pharmaceutical vs. Sandoz Inc.
19 Oct 2018 //
PATENT LITIGATION
FDA Singles Out Three Drug Substances to Not be Compounded
27 Aug 2018 //
RAPS
Vasostrict (Vasopressin) : Athenex Pharma Solutions v. Par Pharmaceutical Inc
18 Aug 2018 //
PATENT LITIGATION
Vasostrict® (Vasopressin): Par Pharmaceutical v. Eagle Pharmaceuticals
31 May 2018 //
PATENT LITIGATION
Enforcement Report - Week of April 25, 2018
25 Apr 2018 //
FDA
Endo International units sue FDA over drug compounding policy
25 Oct 2017 //
REUTERS
